AKV Pharma SPRL
AKV Pharma reported total assets of 58,563 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).
The score of AKV Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets -70 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AKV Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
AKV Pharma's financial analysis
- Solvency89.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AKV Pharma
AKV Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0644.617.062
- VAT number
- BE0644617062
- Peppol
- Registered · 0208:0644617062 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 17 Dec 2015
- Registered office
- 8740 Pittem
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
AKV Pharma (SPRL) has been based in Pittem since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 25,201 € and equity of 52,420 €; its revenue is not published. Its solvency stands at 89.5%, above the median of its sector (44.2%).
Companies similar to AKV Pharma
Companies in the same business, of comparable size and area, outside its group.
- LA Pharmacie DU Parc Retail sale of pharmaceutical products Grez-Doiceau · balance sheet 210,632 €
- Apoteek't Groen Kruis Retail sale of pharmaceutical products Schoten · balance sheet 220,163 €
- Apotheek Bisschoppenhof Retail sale of pharmaceutical products Antwerp · balance sheet 200,383 €
- Apopark Retail sale of pharmaceutical products Leuven · balance sheet 210,821 €
- Genaphar Retail sale of pharmaceutical products Brussels · balance sheet 147,330 €
- Pharmaphie EVG Retail sale of pharmaceutical products Evergem · balance sheet 229,312 €
- Cornut C Retail sale of pharmaceutical products Mons · balance sheet 43,250 €
- Bopre Retail sale of pharmaceutical products Aalst · balance sheet 196,068 €
Frequently asked questions about AKV Pharma
What is the revenue of AKV Pharma?
AKV Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AKV Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0644617062 for AKV Pharma, if the company is VAT-registered. Its company number (CBE) is 0644.617.062.
Where is the registered office of AKV Pharma?
According to the CBE register, the registered office of AKV Pharma is in 8740 Pittem.
What is the equity of AKV Pharma?
At the close of the 2025 financial year, the equity of AKV Pharma amounts to 52,420 €, a solvency of 89.5% of total assets.
Who manages AKV Pharma?
The register lists 2 active mandates at AKV Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AKV Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →